Halia Therapeutics, Inc.

CIK 1829255 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Halia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 31, 2026D0001829255-26-000001
Jul 16, 2025D0001829255-25-000001
Dec 30, 2022D0001829255-22-000001
Feb 17, 2021D0001829255-21-000001
Oct 22, 2020D0001829255-20-000001